Dr. Anne Grosse-Wilde

Angestellt, Manager, Seagen
Vereinigte Staaten

Fähigkeiten und Kenntnisse

cell-based assay development
Cytotoxic drug assays
2D and 3D complex cell co-cultures
multistage mouse tumor models
High throughput single cell qPCR analysis
Antibody development and characterization
Cloning and production of therapeutic fusion prote
Molecular biology techniques
Viral vector technology
Complex data management and analysis
Predictive biomarker signatures
Immunohistochemistry
Protein expression and purification
Receptor-ligand interactions
biomarkers
assay development
RNAseq
NGS
tissue biorepository

Werdegang

Berufserfahrung von Anne Grosse-Wilde

  • Bis heute 8 Jahre und 11 Monate, seit Sep. 2016

    Manager

    Seagen

    Biomarker lead for various solid tumor programs in clinical trials for solid tumor indications for various targeted therapeutics, including antibody drug conjugate (ADCs), combinations of ADCs with IO agents, and small molecule programs

  • 10 Monate, Sep. 2015 - Juni 2016

    Senior Research Scientist

    Nortis, Inc

    • Led research project to generate a novel microfluidics-based vascularized “breast cancer-on-chip” model • Protocol and tool development for quantitation of tumor growth in “cancer-on chip” model • Established anti-cancer drug screening assay in vascularized breast cancer-on-chip model • Augmented experimental capacity by engaging CRO in time-critical project

  • 7 Jahre und 6 Monate, Jan. 2008 - Juni 2015

    Research Scientist

    Institute for Systems Biology

    • Lead cross-functional team of bench scientist and computational biologists for analysis of complex in vitro and in vivo data, biomarker expression, validation using clinical data, and pathway analysis • Identification of biomarker signatures for individual breast cancer stem cells and functional validation in vitro and in primary tumors • Guided interns and research technicians

  • 4 Jahre und 9 Monate, Mai 2003 - Jan. 2008

    Postdoctoral Researcher

    Fred Hutchinson Cancer Research Center

    • Investigated physiological role and cellular antitumorigenic mechanisms of the immune effector TRAIL-R in vitro and in vivo • Examined role of diverse tumor suppressor proteins for sensitivity towards chemotherapy • Identified with TRAIL-R the first in vivo confirmed metastasis suppressor protein in mice

  • 5 Jahre, Jan. 1998 - Dez. 2002

    PhD student

    DKFZ - Deutsches Krebsforschungszentrum

    • Analyzed ligand/receptor-mediated apoptosis signaling pathways in immune cells and tumor cells • Identification and validation of the first murine TRAIL-receptor (TRAIL-R) in mice • Generated and tested protein-based agonistic and antagonistic tools and antibodies • Generated conditional mTRAIL-R knockout mice • Guided interns and research technicians

Ausbildung von Anne Grosse-Wilde

  • 4 Jahre und 1 Monat, Jan. 1998 - Jan. 2002

    Immunogenetics and Cancer

    Bayerische Julius-Maximilians Universität Würzburg

  • 12 Jahre und 11 Monate, Sep. 1994 - Juli 2007

    Biology

    Bayerische Julius-Maximilians Universität Würzburg

    Cell and and Developmental Biology, Genetics, Biochemistry

  • 2 Jahre, Okt. 1992 - Sep. 1994

    Biology

    Friedrich Alexander Universität Erlangen

    Zoology, Botany, Physics, Chemistry

Sprachen

  • Englisch

    Fließend

  • Spanisch

    Grundlagen

  • Deutsch

    Muttersprache

XING – Das Jobs-Netzwerk

  • Über eine Million Jobs

    Entdecke mit XING genau den Job, der wirklich zu Dir passt.

  • Persönliche Job-Angebote

    Lass Dich finden von Arbeitgebern und über 20.000 Recruiter·innen.

  • 22 Mio. Mitglieder

    Knüpf neue Kontakte und erhalte Impulse für ein besseres Job-Leben.

  • Kostenlos profitieren

    Schon als Basis-Mitglied kannst Du Deine Job-Suche deutlich optimieren.

21 Mio. XING Mitglieder, von A bis Z